From: Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya
Primary kidney disease | Gender | Age | All patients | ||
---|---|---|---|---|---|
Male (n=1402) | Female (n=1015) | <50 years (n=1268) | ≥50 years (n=1149) | (n=2417) | |
Diabetic Nephropathy | 396 (28.2)* | 245 (24.1) | 169 (13.3)* | 472 (41.1) | 641 (26.5) |
Hypertensive Nephropathy | 180 (12.8) * | 173 (17) | 129 (10.2)* | 224 (19.5) | 353 (14.6) |
Glomerulonephritis | 318 (22.7) * | 194 (19.1) | 413 (32.6)* | 99 (8.6) | 512 (21.2) |
Interstitial Nephritis | 14 (1) | 15 (1.5) | 17 (1.3) | 12 (1) | 29 (1.2) |
Obstructive Nephritis | 78 (5.6) | 42 (4.1) | 59 (4.7) | 61 (5.3) | 120 (5) |
Chronic pyelonephritis | 19 (1.4) * | 29 (2.9) | 33 (2.6) * | 15 (1.3) | 48 (2) |
Polycystic kidney disease | 82 (5.8) | 70 (6.9) | 68 (5.4) | 84 (7.3) | 152 (6.3) |
Congenital and hereditary diseases | 168 (12) * | 130 (12.8) | 220 (17.3)* | 78 (6.8) | 298 (12.3) |
Autoimmune diseases | 4 (0.3) * | 13 (1.3) | 16 (1.3) * | 1 (0.1) | 17 (0.7) |
Other | 39 (2.8) | 32 (3.2) | 48 (3.8) * | 23 (2) | 71 (2.9) |
Unknown | 104 (7.4) | 72 (7.1) | 96 (7.6) | 80 (7) | 176 (7.3) |